Open AccessPARP Inhibitor Success in Refractory Prostate Cancer
Author(s) -
Peter M. Goodwin
Publication year - 2019
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000615228.82343.17
Subject(s) - olaparib , medicine , oncology , enzalutamide , parp inhibitor , prostate cancer , cohort , progression free survival , cancer , hormonal therapy , chemotherapy , poly adp ribose polymerase , biochemistry , chemistry , androgen receptor , polymerase , gene